-
InDex Pharmaceuticals Holding AB (publ) interim report January – June 2023
August 23, 2023 Regulatory
-
”Positive results from PK study with cobitolimod” selected as one of the best abstracts for poster presentation at UEGW
August 22, 2023 Non Regulatory
InDex Pharmaceuticals published the interim report for Q2 2023 on August 23, 2023.
-
InDex is attending Industrifonden Venture Summit
-
Interim Report Q3 2023
-
Presentation at Redeye Life Science Day 2023